These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. Yu C, Storb R, Deeg HJ, Graham TC, Scheuning FG, Huss R, Seidel K, Fitzsimmons WE. Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370 [Abstract] [Full Text] [Related]
3. Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis. Yagasaki H, Kojima S, Yabe H, Kato K, Kigasawa H, Sakamaki H, Tsuchida M, Kato S, Kawase T, Muramatsu H, Morishima Y, Kodera Y. Biol Blood Marrow Transplant; 2009 Dec; 15(12):1603-8. PubMed ID: 19896085 [Abstract] [Full Text] [Related]
5. Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation. Yu C, Seidel K, Fitzsimmons WE, Sale G, Storb R. Bone Marrow Transplant; 1997 Jul; 20(2):137-41. PubMed ID: 9244417 [Abstract] [Full Text] [Related]
14. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. Ogawa H, Soma T, Hosen N, Tatekawa T, Tsuboi A, Oji Y, Tamaki H, Kawakami M, Ikegame K, Murakami M, Fujioka T, Kim EH, Oka Y, Sugiyama H. Transplantation; 2002 Jul 27; 74(2):236-43. PubMed ID: 12151737 [Abstract] [Full Text] [Related]
16. Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan. Koga Y, Nagatoshi Y, Kawano Y, Okamura J. Bone Marrow Transplant; 2003 Jul 27; 32(2):171-6. PubMed ID: 12838282 [Abstract] [Full Text] [Related]
18. Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs. Kolb H, Sale GE, Lerner KG, Storb R, Thomas ED. Am J Pathol; 1979 Aug 27; 96(2):581-94. PubMed ID: 38670 [Abstract] [Full Text] [Related]
19. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS, Kwak DH, Jeon YW, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Lee JW. Biol Blood Marrow Transplant; 2017 Sep 27; 23(9):1498-1508. PubMed ID: 28554856 [Abstract] [Full Text] [Related]
20. Marrow grafts between DLA-identical and homozygous unrelated dogs: evidence for an additional locus involved in graft-versus-host disease. Storb R, Weiden PL, Graham TC, Lerner KG, Thomas ED. Transplantation; 1977 Sep 27; 24(3):165-74. PubMed ID: 22945 [Abstract] [Full Text] [Related] Page: [Next] [New Search]